共有 50 笔近期内部人交易记录记录,涉及 DBV Technologies S.A. (DBVT), 包括 24 笔买入 和 18 笔卖出. 内部人买入总额为 $9.68M 内部人卖出总额为 $5.67M.
近期活跃的重要内部人包括 Mohideen Pharis, Baker Bros. Advisors Lp, Epic Bpifrance. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — DBVT
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-01-29 |
Mohideen Pharis |
Chief Medical Officer |
知情卖出 |
534 |
$4.86 |
$2.6K |
144,995 |
| 2026-01-12 |
Baker Bros. Advisors Lp |
Director |
期权行权(卖出) |
25,005,240 |
- |
- |
- |
| 2025-12-18 |
Epic Bpifrance |
Other: Member of 10% Owner Group |
知情卖出 |
1,292,103 |
$4.19 |
$5.41M |
7,303,369 |
| 2025-12-17 |
Epic Bpifrance |
Other: Member of 10% Owner Group |
知情卖出 |
40,000 |
$5.28 |
$211.2K |
8,595,472 |
| 2025-11-21 |
Tasse Daniel |
Chief Executive Officer |
限制性股票授予 (RSU) |
964,000 |
$2.90 |
$2.8M |
964,000 |
| 2025-11-21 |
Boucinha Virginie |
Chief Financial Officer |
限制性股票授予 (RSU) |
32,000 |
- |
- |
70,000 |
| 2025-11-21 |
Trapp Kevin Michael |
Chief Commercial Officer |
限制性股票授予 (RSU) |
55,000 |
- |
- |
55,000 |
| 2025-11-21 |
Mohideen Pharis |
Chief Medical Officer |
知情卖出 |
1,624 |
$2.77 |
$4.5K |
101,529 |
| 2025-11-20 |
Mohideen Pharis |
Chief Medical Officer |
知情卖出 |
6,496 |
$2.88 |
$18.71K |
103,153 |
| 2025-11-03 |
Trapp Kevin Michael |
Officer |
未知 |
- |
- |
- |
- |
| 2025-07-29 |
Mohideen Pharis |
Chief Medical Officer |
知情卖出 |
464 |
$2.22 |
$1.03K |
109,649 |
| 2025-05-22 |
Mohideen Pharis |
Chief Medical Officer |
知情卖出 |
397 |
$1.84 |
$730.48 |
110,113 |
| 2025-04-07 |
Bpifrance Sa |
10 Percent Owner |
未知 |
6,556,781 |
- |
- |
- |
| 2025-04-07 |
Epic Bpifrance |
Other: Member of 10% Owner Group |
未知 |
6,556,781 |
- |
- |
- |
| 2025-03-27 |
Baker Bros. Advisors Lp |
10 Percent Owner |
限制性股票授予 (RSU) |
2,299,656 |
- |
- |
2,299,656 |
| 2025-03-27 |
Bpifrance Sa |
10 Percent Owner |
未知 |
- |
- |
- |
226,133 |
| 2025-03-27 |
Bpifrance Investissement S.a.s. |
Other: Member of 10% Owner Group |
未知 |
- |
- |
- |
226,133 |
| 2025-03-27 |
Epic Bpifrance |
Other: Member of 10% Owner Group |
未知 |
- |
- |
- |
226,133 |
| 2025-01-30 |
Mohideen Pharis |
Chief Medical Officer |
知情卖出 |
600 |
$0.85 |
$510.00 |
110,510 |
| 2024-12-04 |
Tasse Daniel |
Chief Executive Officer |
限制性股票授予 (RSU) |
813,200 |
$0.89 |
$723.75K |
813,200 |
| 2024-11-25 |
Mohideen Pharis |
Chief Medical Officer |
知情卖出 |
565 |
$0.57 |
$322.05 |
111,110 |
| 2024-11-22 |
Mohideen Pharis |
Chief Medical Officer |
知情卖出 |
342 |
$0.53 |
$181.26 |
111,675 |
| 2024-11-21 |
Mohideen Pharis |
Chief Medical Officer |
知情卖出 |
2,350 |
$0.54 |
$1.27K |
112,017 |
| 2024-11-21 |
Boucinha Virginie |
Chief Financial Officer |
限制性股票授予 (RSU) |
19,000 |
- |
- |
38,000 |
| 2024-07-29 |
Mohideen Pharis |
Chief Medical Officer |
知情卖出 |
1,785 |
$0.98 |
$1.75K |
79,367 |
| 2024-05-24 |
Mohideen Pharis |
Chief Medical Officer |
知情卖出 |
660 |
$1.36 |
$897.60 |
81,152 |
| 2024-05-22 |
Mohideen Pharis |
Chief Medical Officer |
知情卖出 |
382 |
$1.38 |
$527.16 |
81,812 |
| 2024-03-08 |
Tasse Daniel |
Chief Executive Officer |
知情买入 |
17,094 |
$0.83 |
$14.19K |
17,094 |
| 2024-02-06 |
Ndu Adora |
Director |
知情买入 |
1,825 |
$0.89 |
$1.62K |
1,825 |
| 2023-11-22 |
Mohideen Pharis |
Chief Medical Officer |
知情卖出 |
2,245 |
$1.74 |
$3.91K |
82,194 |
| 2023-11-20 |
Tasse Daniel |
Chief Executive Officer |
限制性股票授予 (RSU) |
806,672 |
$2.19 |
$1.77M |
806,672 |
| 2023-11-20 |
Mohideen Pharis |
Chief Medical Officer |
限制性股票授予 (RSU) |
35,000 |
- |
- |
84,439 |
| 2023-11-20 |
Boucinha Virginie |
Chief Financial Officer |
限制性股票授予 (RSU) |
19,000 |
- |
- |
19,000 |
| 2023-11-06 |
Boucinha Virginie |
Officer |
未知 |
- |
- |
- |
- |
| 2023-08-25 |
Morris Timothy E |
Director |
知情买入 |
12,000 |
$1.52 |
$18.24K |
12,000 |
| 2023-08-01 |
Soland Daniel B |
Director |
知情买入 |
15,000 |
$1.62 |
$24.3K |
20,000 |
| 2023-05-24 |
Mohideen Pharis |
Chief Medical Officer |
知情卖出 |
469 |
$3.54 |
$1.66K |
49,439 |
| 2022-11-24 |
Mohideen Pharis |
Chief Medical Officer |
知情卖出 |
1,792 |
$2.88 |
$5.16K |
49,908 |
| 2022-11-21 |
Tasse Daniel |
Chief Executive Officer |
限制性股票授予 (RSU) |
764,386 |
$3.07 |
$2.35M |
764,386 |
| 2022-11-21 |
Mohideen Pharis |
Chief Medical Officer |
限制性股票授予 (RSU) |
17,500 |
- |
- |
51,700 |
| 2022-11-21 |
Robitaille Sebastien |
Chief Financial Officer |
限制性股票授予 (RSU) |
8,000 |
- |
- |
36,500 |
| 2022-10-03 |
Guyot-caparros Daniele |
Director |
未知 |
- |
- |
- |
- |
| 2022-07-29 |
Mohideen Pharis |
Chief Medical Officer |
限制性股票授予 (RSU) |
10,000 |
- |
- |
34,200 |
| 2022-06-13 |
Baker Bros. Advisors Lp |
10 Percent Owner |
限制性股票授予 (RSU) |
1,383,352 |
- |
- |
1,383,352 |
| 2022-06-13 |
Baker Brothers Life Sciences Lp |
Director |
限制性股票授予 (RSU) |
1,383,352 |
- |
- |
1,383,352 |
| 2021-11-22 |
Tasse Daniel |
Chief Executive Officer |
限制性股票授予 (RSU) |
274,000 |
$6.62 |
$1.81M |
274,000 |
| 2021-11-22 |
Mohideen Pharis |
Chief Medical Officer |
限制性股票授予 (RSU) |
8,700 |
- |
- |
24,200 |
| 2021-11-22 |
Robitaille Sebastien |
Chief Financial Officer |
限制性股票授予 (RSU) |
5,000 |
- |
- |
28,500 |
| 2021-06-10 |
De Rosen Michel |
Director |
知情买入 |
6,837 |
$13.09 |
$89.5K |
6,837 |
| 2021-06-10 |
Morris Timothy E |
Director |
知情买入 |
6,837 |
$13.09 |
$89.5K |
6,837 |
■ 知情交易 — 公开市场买卖(最具参考价值)
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期